Skip to main content
. 2020 Oct 11;12(10):3089. doi: 10.3390/nu12103089

Figure 1.

Figure 1

Protease-treated royal jelly (pRJ) prevents skeletal muscle atrophy following denervation. The effect of dietary protease-treated royal jelly (pRJ) on (A) total body weight and (B) wet weight of tibialis anterior (TA) muscles following denervation (DN). (C) Representative images of TA muscle cross-sections and (D) quantification of muscle cross-sectional area (CSA). Scale = 100 μm. Data are mean ± SD (n = 10). ∗∗p < 0.01, versus sham-operated (Sham). ∗p < 0.05, versus control (Ctrl). No significant difference (ND), versus Sham.